Dr. Vivian W. Tsai, MD

Dr. Tsai practices at Palo Alto Medical Foundation-Fremont Center in Fremont, California.

Dr. Tsai's NPI, 1770534182, was assigned on May 12, 2006. Dr. Tsai graduated from The Johns Hopkins University School of Medicine in 2003. Dr. Tsai holds California license A88245.

Dr. Tsai's primary practice is Palo Alto Medical Foundation-Fremont Center, at 3200 Kearney Street, Fremont, CA 94538. The practice phone is (510) 498-2812.

Dr. Tsai's primary practice is Palo Alto Medical Foundation-Fremont Center in Fremont, California. Dr. Tsai is also affiliated with Washington Health. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Tsai to 1 more group practice or clinic, named with a free account. Dr. Tsai's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tsai practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Tsai's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Tsai is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Tsai is licensed in California.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, congestive heart failure and coronary artery disease among the conditions Dr. Tsai treats.

CMS data shows 2,813 Medicare services from Dr. Tsai across 24 procedure codes in 2024, for 1,149 Medicare patients. Medicare paid $233,656 for them.

CMS counts 1,149 Medicare patients who saw Dr. Tsai in 2024. The largest group is 75 to 84, with 459 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tsai's median patient age at 59, with 49% women.

In 2024, Dr. Tsai wrote 5,010 Medicare Part D claims for 379 patients. 87% of them were for generic drugs. CMS names the drug for 4,730 of them, across 43 drugs with 11 or more claims each, at $852,433 in total drug cost. In 2023, CMS named 4,601 claims across 46 drugs.

Dr. Tsai accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tsai as offering telehealth.

Dmand AI links 9 papers to Dr. Tsai, published from 2007 to 2015. 2015 was the busiest year, with 3. The most frequent topics are Defibrillators, Implantable, Heart Failure and Comorbidity. Dr. Tsai has published most often in Circ Cardiovasc Qual Outcomes. Dr. Tsai's most frequent co-authors are Paul Allen Heidenreich, MD, Mary K. Goldstein, MD and Henry H. Hsia, MD.

CMS Open Payments shows 3 general payments to Dr. Tsai from 3 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Cleerly, Inc. paid the most, $48.

Dmand AI lists 1 award for Dr. Tsai, most recently CMS Stage 1 EHR in 2013.

Dr. Tsai graduated from The Johns Hopkins University School of Medicine in 2003. Dr. Tsai is a member of ACC.

Dr. Tsai is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.